Fig. 5 | Hypertension Research

Fig. 5

From: Dark-phase melatonin administration does not reduce blood pressure but induces changes in parameters related to the control of the cardiovascular system in spontaneously hypertensive rats

Fig. 5

Relative expression of proteins in the kidney (A–D) and adrenal gland (E, F) in rats with the nocturnal melatonin administration at three concentrations (Mel2, n = 4; Mel10, n = 5 and Mel45, n = 7) and in the placebo (P, n = 6) group. The graphs contain the results of unpaired t-tests (WT, n = 4 vs SHR, n = 6) and one-way ANOVA. CD68 Cluster of Differentiation 68 – a protein highly expressed by cells in the monocyte lineage (observed 47 kDa), eNOS endothelial nitric oxide synthase (observed 140 kDa), ENaC epithelial sodium channels family (observed 76 kDa), GAPDH glyceraldehyde 3-phosphate dehydrogenase (observed 36 kDa), MAO-A monoamine oxidase A (observed 60 kDa), TGF-β1 transforming growth factor beta 1 (observed 44 kDa), TH tyrosine hydroxylase (observed 60 kDa), WT Wistar rats, SHR spontaneously hypertensive rats. Data are visualised as individual datapoints and arithmetic mean ± the standard error of the mean

Back to article page